454 Life Sciences Initiates Collaborative Research Agreement with the Broad Institute Collaboration Aims to Facilitate Disease-Related Genomic Studies
21 Dec 2005 -
454 Life Sciences Corporation announced the initiation of a collaborative research agreement with the Broad Institute of MIT and Harvard, a research collaboration of the Massachusetts Institute of Technology, Harvard University and its hospitals and the Whitehead Institute for Biomedical Research. Under the collaboration, researchers at the Broad Institute will use 454 Life Sciences' system to conduct
disease-related genomic studies in order to study the genetic basis for complex diseases, such as cancer, diabetes and heart disease. 454 Life Sciences has enabled its Genome Sequencer 20 System to perform "Ultra-deep Sequencing"(TM) of specific genes of interest for use in the collaboration.
Additional information
Broad Institute of MIT and Harvard Cambridge, MA, United States of America
Top
Contact
Print version
PDF version
Send article
RSS-Feed